cyclopentane has been researched along with Cancer of Prostate in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajo, AM; Bryszewska, M; de la Mata, FJ; García-Gallego, S; Gómez, R; Ionov, M; Ortega, P; Sanz Del Olmo, N | 1 |
| Bacsa, J; Goodman, MM; Liebeskind, LS; Nye, JA; Olson, JJ; Pickel, TC; Voll, RJ; Wang, Z; Yu, W | 1 |
| Bouchal, J; Gachechiladze, M; Kharaishvili, G; Kral, M; Kurfurstova, D; Mickova, A; Mistrik, M; Pokryvkova, B; Soucek, K; Vacek, O | 1 |
| Chun, YS; Lee, GW; Li, L; Park, JW; Park, SY | 1 |
| Choi, SK; Han, DC; Jin, Y; Kim, YH; Kwon, BM; Lee, YJ; Oh, HM; Park, JY | 1 |
| Gano, L; Garcia, MH; Gonçalves, MS; Jorge, TF; Marques, F; Martins, M; Matos, AP; Morais, TS; Pinheiro, T; Tomaz, AI; Tortosa, F; Valente, A | 1 |
| Berman-Booty, LD; Clinton, SK; Erdman, JW; Jeffery, EH; Juvik, JA; Liu, AG | 1 |
| Feng, Y; Fu, S; Guo, X; Jeong, LS; Jia, L; Li, C; Li, L; Liang, Y; Sun, M; Wang, X; Ye, D; Zhao, H | 1 |
| Dai, X; Ding, Q; Gan, W; Li, M; Mitsiades, N; Wan, L; Wei, W; Wu, F; Zhang, J | 1 |
| Assard, N; Balakirev, MY; Dolega, ME; Gerbaud, S; Gidrol, X; Guyon, L; Kermarrec, F; Mittler, F; Obeid, P; Rulina, AV; Sulpice, E | 1 |
| Bozeman, E; Devineni, D; Ezekwudo, D; Palaniappan, R; Selvaraj, P; Shashidharamurthy, R | 1 |
| Bathina, M; Carper, SW; Elegbede, A; Pierre, KJ; Yeruva, L | 1 |
| Chan, ES; Chan, QK; Ho, SM; Lam, HM; Lau, KM; Lee, AY; Ng, CF; Ng, HK | 1 |
| Gu, C; Jiang, G; Luo, B; Tao, D; Tong, Q; Wang, L; Xiao, X; Zeng, F; Zhao, J | 1 |
| Caggia, S; Cardile, V; Carvajal, TM; Espinoza, CL; Garbarino, JA; Peña-Cortés, H; Russo, A | 1 |
| Elegbede, JA; Ezekwudo, DE; Wang, RC | 1 |
| Fletcher, JG; Fossel, ET; Hui, KK; Zanella, CL | 1 |
| Chen, Y; Konno, S; Mallouh, C; Mordente, JA; Tazaki, H; Wu, JM | 1 |
| Barrero, AF; Christophersen, C; Justicia, J; Malmstrøm, J; Oltra, JE; Rosales, A | 1 |
| Holtzhausen, GH | 1 |
1 review(s) available for cyclopentane and Cancer of Prostate
| Article | Year |
|---|---|
[Clinical aspects of the anti-androgens].
Topics: 17-Ketosteroids; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Androsterone; Contraceptives, Oral, Hormonal; Cyclopentanes; Cyproterone; Dermatitis, Seborrheic; Dihydrotestosterone; Estradiol Congeners; Female; Follicle Stimulating Hormone; Glucocorticoids; Hirsutism; Humans; Hydroxysteroids; Luteinizing Hormone; Male; Medroxyprogesterone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Sex Hormone-Binding Globulin; Steroids; Testosterone | 1979 |
19 other study(ies) available for cyclopentane and Cancer of Prostate
| Article | Year |
|---|---|
Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; Dendrimers; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Organometallic Compounds; Prostatic Neoplasms; Ruthenium; Silanes; Structure-Activity Relationship | 2020 |
Synthesis, Radiolabeling, and Biological Evaluation of the
Topics: Animals; Carboxylic Acids; Cyclopentanes; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Glioblastoma; Humans; Male; Molecular Conformation; Molecular Structure; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Tumor Cells, Cultured | 2020 |
Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; Cyclopentanes; Docetaxel; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; NEDD8 Protein; Neoplasm Grading; PC-3 Cells; Prostate; Prostatic Neoplasms; Protein Processing, Post-Translational; Pyrimidines; Receptors, Androgen; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Snail Family Transcription Factors | 2021 |
Inhibition of neddylation facilitates cell migration through enhanced phosphorylation of caveolin-1 in PC3 and U373MG cells.
Topics: Caveolin 1; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclopentanes; Humans; Male; NEDD8 Protein; Phosphorylation; Prostatic Neoplasms; Proteolysis; Pyrimidines; Signal Transduction; Ubiquitin-Activating Enzymes | 2018 |
Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells.
Topics: Cyclopentanes; Dose-Response Relationship, Drug; Humans; Lauraceae; Male; Molecular Structure; Prostatic Neoplasms; Protein Tyrosine Phosphatases, Non-Receptor; STAT3 Transcription Factor; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Coordination Complexes; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Liver; Male; Prostatic Neoplasms; Ruthenium | 2019 |
Enhancement of broccoli indole glucosinolates by methyl jasmonate treatment and effects on prostate carcinogenesis.
Topics: Acetates; Animals; Brassica; Carcinogenesis; Cyclopentanes; Glucosinolates; Indoles; Male; Mice, Inbred C57BL; Oxylipins; Plant Extracts; Plant Growth Regulators; Prostatic Neoplasms | 2014 |
Targeting the neddylation pathway to suppress the growth of prostate cancer cells: therapeutic implication for the men's cancer.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cullin Proteins; Cyclopentanes; DNA Damage; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Pyrimidines; Signal Transduction; Ubiquitin-Protein Ligases; Ubiquitins | 2014 |
Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
Topics: Antineoplastic Agents; Carbamates; Cdc20 Proteins; Cullin Proteins; Cyclopentanes; Diamines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; HeLa Cells; Humans; Male; Molecular Targeted Therapy; Mutation; Nuclear Proteins; Prostatic Neoplasms; Protein Interaction Domains and Motifs; Proteolysis; Pyrimidines; Repressor Proteins; Time Factors; Transfection; Ubiquitination | 2017 |
Distinct outcomes of CRL-Nedd8 pathway inhibition reveal cancer cell plasticity.
Topics: Cell Line, Tumor; Cell Lineage; Cell Plasticity; Cell Proliferation; Cell Survival; Cyclopentanes; Gene Knockdown Techniques; Humans; Male; Models, Biological; NEDD8 Protein; Prostatic Neoplasms; Pyrimidines; Receptors, Androgen; Signal Transduction; Spheroids, Cellular; Transcription, Genetic; Transcriptional Regulator ERG; Ubiquitin-Protein Ligases; Ubiquitins | 2016 |
Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate.
Topics: Acetates; Adenocarcinoma; Annexin A5; Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Gamma Rays; Humans; Male; Oxylipins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Radiation-Sensitizing Agents | 2008 |
Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells.
Topics: Acetates; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Humans; Male; Oxylipins; Prostatic Neoplasms; Receptors, Tumor Necrosis Factor, Type I | 2008 |
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclopentanes; Extracellular Signal-Regulated MAP Kinases; Flavonoids; G2 Phase; Gene Expression; Humans; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction; Xenograft Model Antitumor Assays | 2010 |
AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis.
Topics: Acetates; Amino Acid Sequence; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Humans; Inhibitor of Apoptosis Proteins; Male; Oligopeptides; Oxylipins; Prostatic Neoplasms; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein | 2011 |
A new jasmonic acid stereoisomeric derivative induces apoptosis via reactive oxygen species in human prostate cancer cells.
Topics: Apoptosis; Cyclopentanes; Humans; Male; Oxylipins; Prostatic Neoplasms; Reactive Oxygen Species; Stereoisomerism | 2012 |
Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway.
Topics: Acetates; Anticarcinogenic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Cycle; Cell Line, Tumor; Cyclopentanes; Humans; Male; Oxylipins; Prostatic Neoplasms | 2007 |
Cell death induced by peroxidized low-density lipoprotein: endopepsis.
Topics: Adenocarcinoma; Brefeldin A; Cell Death; Cyclopentanes; Drug Synergism; Endopeptidases; Fibrosarcoma; Hip; Humans; Hydrolases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipoproteins, LDL; Lysosomes; Male; Mitochondria; Neoplasms, Experimental; Peroxides; Prostatic Neoplasms; Protein Synthesis Inhibitors; Receptors, LDL; Tumor Cells, Cultured | 1994 |
The effects of brefeldin A (BFA) on cell cycle progression involving the modulation of the retinoblastoma protein (pRB) in PC-3 prostate cancer cells.
Topics: Brefeldin A; Cell Division; Cyclin-Dependent Kinases; Cyclopentanes; G1 Phase; Humans; Male; Phosphorylation; Prostatic Neoplasms; Protein Synthesis Inhibitors; Retinoblastoma Protein; S Phase; Time Factors; Tumor Cells, Cultured | 1998 |
Bioactive metabolites from a marine-derived strain of the fungus Emericella variecolor.
Topics: Animals; Antibiotics, Antineoplastic; Antifungal Agents; Benzyl Alcohols; Breast Neoplasms; Caribbean Region; Central Nervous System Neoplasms; Colonic Neoplasms; Cyclopentanes; Drug Screening Assays, Antitumor; Ergosterol; Female; Fungi; Furans; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kidney Neoplasms; Leukemia P388; Lung Neoplasms; Male; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Porifera; Prostatic Neoplasms; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured; Xanthenes; Xanthones | 2002 |